Skip to main content
Top
Published in: Heart and Vessels 9/2016

01-09-2016 | Original Article

Risk factors and serological markers of liver cirrhosis after Fontan procedure

Authors: Mikiko Shimizu, Kenji Miyamoto, Yunosuke Nishihara, Gaku Izumi, Shuji Sakai, Kei Inai, Toshio Nishikawa, Toshio Nakanishi

Published in: Heart and Vessels | Issue 9/2016

Login to get access

Abstract

Liver cirrhosis (LC), which may result in hepatic failure or cancer, has been reported in patients after Fontan procedure. The purpose of this study was to clarify the frequency and histological characteristics of LC, and to evaluate the risk factors and serological markers of LC with Fontan circulation. Retrospective review of contrast-enhanced CT scans (CT) of the liver was carried out in 57 patients after Fontan procedure. Patients were divided into two groups: LC group (n = 31) and no LC group (n = 26). Age at Fontan procedure, duration after Fontan procedure, catheterization data, and history of failing Fontan circulation were compared between groups. Serological data including γ-GTP and hyaluronic acid were compared. Histology of autopsy specimens was assessed when available. Duration after Fontan procedure was significantly longer in LC group than no LC group. History of failing Fontan circulation was more frequent in LC group than in no LC group. There was no correlation between type of procedure (APC/Bjork/lateral tunnel/TCPC) and LC in this series. Serum hyaluronic acid, γ-GTP, and Forns index were significantly higher in LC group. Significant risk factors for LC were duration after Fontan procedure (>20 years). In autopsy specimens, histopathological changes of LC were observed predominantly in the central venous area. LC diagnosed with CT is frequent in patients long after Fontan procedure, especially after 20 years. Hyaluronic acid and γ-GTP could be useful markers to monitor the progression of liver fibrosis in Fontan patients.
Literature
2.
go back to reference Motoki N, Ohuchi H, Miyazaki A, Yamada O (2009) Clinical Profiles of Adult patient with single ventricle physiology. Circ J 73(9):1711–1716CrossRefPubMed Motoki N, Ohuchi H, Miyazaki A, Yamada O (2009) Clinical Profiles of Adult patient with single ventricle physiology. Circ J 73(9):1711–1716CrossRefPubMed
3.
go back to reference Sarkola T, Jaeggi E, Slorach C, Hui W, Bradley T, Redington AN (2013) Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up. Heart Vessels 28(1):66–75CrossRefPubMed Sarkola T, Jaeggi E, Slorach C, Hui W, Bradley T, Redington AN (2013) Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up. Heart Vessels 28(1):66–75CrossRefPubMed
4.
go back to reference Olivier M, O’Leary PW, Pankratz VS, Lohse CM, Walsh BE, Tajik AJ, Seward JB (2003) Serial Doppler assessment of diastolic function before and after the Fontan operation. J Am Soc Echocardiogr 16:1136–1143CrossRefPubMed Olivier M, O’Leary PW, Pankratz VS, Lohse CM, Walsh BE, Tajik AJ, Seward JB (2003) Serial Doppler assessment of diastolic function before and after the Fontan operation. J Am Soc Echocardiogr 16:1136–1143CrossRefPubMed
5.
go back to reference Shachar GB, Fuhrman BP, Wang Y, Lucas RV Jr, Lock JE (1982) Rest and exercise hemodynamics after the Fontan procedure. Circulation 65:1043–1048CrossRefPubMed Shachar GB, Fuhrman BP, Wang Y, Lucas RV Jr, Lock JE (1982) Rest and exercise hemodynamics after the Fontan procedure. Circulation 65:1043–1048CrossRefPubMed
6.
go back to reference Nieuwenhuizen RC, Peter M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ (1999) Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 82(1):40–46CrossRefPubMedPubMedCentral Nieuwenhuizen RC, Peter M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ (1999) Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 82(1):40–46CrossRefPubMedPubMedCentral
7.
go back to reference Tomita H, Yamada O, Ohuchi Ono Y, Arakaki Y, Yagihara T, Echigo S (2001) Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young 11(1):62–66CrossRefPubMed Tomita H, Yamada O, Ohuchi Ono Y, Arakaki Y, Yagihara T, Echigo S (2001) Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young 11(1):62–66CrossRefPubMed
8.
go back to reference Cheung EW, Chay GW, Ma ES, Systemic Cheung YF (2005) Oxygen saturations and coagulation factor abnormalities before and after the Fontan procedure. Am J Cardiol 96(11):1571–1575CrossRefPubMed Cheung EW, Chay GW, Ma ES, Systemic Cheung YF (2005) Oxygen saturations and coagulation factor abnormalities before and after the Fontan procedure. Am J Cardiol 96(11):1571–1575CrossRefPubMed
9.
go back to reference Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kuromann O, Pedersen J, Sorensen KE (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85(1):61–65CrossRefPubMedCentral Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kuromann O, Pedersen J, Sorensen KE (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85(1):61–65CrossRefPubMedCentral
10.
go back to reference Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP (2008) Hepatic fibrosis and cirrhosis in Fontan circulation: a detailed morphological study. J Clin Pathol 61(4):504–508CrossRefPubMed Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP (2008) Hepatic fibrosis and cirrhosis in Fontan circulation: a detailed morphological study. J Clin Pathol 61(4):504–508CrossRefPubMed
11.
go back to reference Kieswetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, Haw M, Cope R, Salmon AP, Sivaprakasam MC, Kendall T, Keeton BR, Iredale JP, Veldtman GR (2007) Hepatic changes in failing Fontan circulation. Heart 93(5):579–584CrossRef Kieswetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, Haw M, Cope R, Salmon AP, Sivaprakasam MC, Kendall T, Keeton BR, Iredale JP, Veldtman GR (2007) Hepatic changes in failing Fontan circulation. Heart 93(5):579–584CrossRef
12.
go back to reference Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348–1352CrossRefPubMed Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348–1352CrossRefPubMed
13.
go back to reference Friedrich-Rust M, Koch C, Rentzsch A, Sarrazim C, Schwarz P, Herrmann E, Lindinger A, Sarrazin U, Poynard T, Schäfers HJ, Zeuzem S, Abdul-Khaliq H (2008) Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cariovasc Surg 135:560–567CrossRef Friedrich-Rust M, Koch C, Rentzsch A, Sarrazim C, Schwarz P, Herrmann E, Lindinger A, Sarrazin U, Poynard T, Schäfers HJ, Zeuzem S, Abdul-Khaliq H (2008) Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cariovasc Surg 135:560–567CrossRef
14.
go back to reference Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: concise review. Am J Gastroenterol 99(6):1160–1174CrossRefPubMed Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: concise review. Am J Gastroenterol 99(6):1160–1174CrossRefPubMed
15.
go back to reference Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, Itani T, Kasugai H, Kanematsu M, Ito K, Usuki N, Shimamatsu K, Kage M, Kojiro M (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 51(suppl 1):17–26CrossRefPubMed Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, Itani T, Kasugai H, Kanematsu M, Ito K, Usuki N, Shimamatsu K, Kage M, Kojiro M (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 51(suppl 1):17–26CrossRefPubMed
16.
go back to reference Ginde S, Hohenwalter D, Foley D, Sowinski J, Bartz J, Venkatapuram S, Weinberg C, Tweddell S, Earing G (2012) Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure. Congenit Heart Dis 7:235–242CrossRefPubMed Ginde S, Hohenwalter D, Foley D, Sowinski J, Bartz J, Venkatapuram S, Weinberg C, Tweddell S, Earing G (2012) Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure. Congenit Heart Dis 7:235–242CrossRefPubMed
17.
go back to reference Terjung B, Lemnitzer I, Dumoulin FL, Effenberger W, Brackmann HH, Sauerbruch T, Spengler U (2003) Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67:138–145CrossRefPubMed Terjung B, Lemnitzer I, Dumoulin FL, Effenberger W, Brackmann HH, Sauerbruch T, Spengler U (2003) Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67:138–145CrossRefPubMed
18.
go back to reference Baek S, Bae J, Ho S, Kim B, Lee Y, Noh L, Park A, Lee W (2010) Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart 96:1750–1755CrossRefPubMed Baek S, Bae J, Ho S, Kim B, Lee Y, Noh L, Park A, Lee W (2010) Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart 96:1750–1755CrossRefPubMed
19.
go back to reference Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by simple predictive model. Hepatology 36:986–992CrossRefPubMed Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by simple predictive model. Hepatology 36:986–992CrossRefPubMed
20.
go back to reference Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pudifin DJ (1986) Sampling variability and its influence on the liver. Lancet 1:523–525CrossRefPubMed Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pudifin DJ (1986) Sampling variability and its influence on the liver. Lancet 1:523–525CrossRefPubMed
21.
go back to reference Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Gardini C, Martinelli F, Polchi P, Polizzi V, Ripalti M (1995) Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 89:757–761CrossRefPubMed Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Gardini C, Martinelli F, Polchi P, Polizzi V, Ripalti M (1995) Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 89:757–761CrossRefPubMed
22.
go back to reference Bedossa P, Dargere D, Paradise V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449–1457CrossRefPubMed Bedossa P, Dargere D, Paradise V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449–1457CrossRefPubMed
23.
go back to reference Hayashi T, Inuzuka R, Shindo T, Hirata Y, Shimizu N, Oka A (2014) Serum Hyaluronic acid concentration in Fontan circulation: Correlation with hepatic function and portal vein hemodynamics. Pediatr Cardiolo 35:608–615CrossRef Hayashi T, Inuzuka R, Shindo T, Hirata Y, Shimizu N, Oka A (2014) Serum Hyaluronic acid concentration in Fontan circulation: Correlation with hepatic function and portal vein hemodynamics. Pediatr Cardiolo 35:608–615CrossRef
Metadata
Title
Risk factors and serological markers of liver cirrhosis after Fontan procedure
Authors
Mikiko Shimizu
Kenji Miyamoto
Yunosuke Nishihara
Gaku Izumi
Shuji Sakai
Kei Inai
Toshio Nishikawa
Toshio Nakanishi
Publication date
01-09-2016
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 9/2016
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0743-4

Other articles of this Issue 9/2016

Heart and Vessels 9/2016 Go to the issue